SCHEMBL27891786

SCHEMBL27891786

CCN(CC)CCCCN(C)c1cc2c3ccccc3n(C)c2c(C)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A2 P23975 1/20 0.42
HRH1 P35367 1/20 0.42
RCE1 Q9Y256 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
HSD17B10 Q99714 3/20 0.39
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
RAD52 P43351 1/20 0.38
RAB9A P51151 1/20 0.38
SMARCA2 P51531 1/20 0.38
TP53 P04637 3/20 0.38
PKM P14618 1/20 0.38
CACNA2D1 P54289 1/20 0.37
KIT P10721 1/20 0.37
PDGFRA P16234 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27891745 0.93 RCE1 (0.42) ABCB1SLC6A4SLC6A2HRH1RCE1
SCHEMBL27891739 0.84 ABCB1 (0.41) ABCB1SLC6A4SLC6A2HRH1SMN1; SMN2
SCHEMBL27891766 0.84 ABCB1 (0.46) ABCB1SLC6A4SLC6A2HRH1SMN1; SMN2
SCHEMBL27908739 0.79 SLC6A4 (0.43) ABCB1SLC6A4SLC6A2HRH1RCE1
SCHEMBL27908738 0.78 ABCB1 (0.42) ABCB1SLC6A4SLC6A2HRH1SMN1; SMN2
SCHEMBL27891749 0.77 KMT2A (0.42) SMN1; SMN2KDM4EHSD17B10NPC1POLB
SCHEMBL28374231 0.73 CXCR4 (0.40) ABCB1RCE1ALKBH5FTO
SCHEMBL28379342 0.72 CXCR4 (0.40) SLC6A4SLC6A2HRH1RCE1ALKBH5
SCHEMBL27891741 0.71 RCE1 (0.41) SLC6A4SLC6A2HRH1RCE1SMN1; SMN2
SCHEMBL27979712 0.68 ALKBH5 (0.49) KDM4EALDH1A1HSD17B10GAATOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102146080-B Beta-carboline alkali derivative compounds and application thereof XINJIANG HUASHIDAN PHARMACEUTICAL CO LTD 2013-01-30 CN disclosed